AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENTCredit and Guaranty Agreement • November 5th, 2012 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT, dated as of March 6, 2012 (this "Amendment No. 1"), by and among VALEANT PHARMACEUTICALS INTERNATIONAL, INC., a corporation continued under the federal laws of Canada ("Borrower"), Goldman Sachs Lending Partners LLC, as Administrative Agent ("Administrative Agent") and Collateral Agent under the Credit Agreement (as defined below), and the Requisite Lenders.
JOINDER AGREEMENTJoinder Agreement • November 5th, 2012 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
This Joinder Agreement is dated as of September 11, 2012 (this "Agreement"), by and among each of the financial institutions set forth on Schedule A annexed hereto (each a "New Revolving Loan Lender" and collectively the "New Revolving Loan Lenders"), Valeant Pharmaceuticals International, Inc., a corporation continued under the federal laws of Canada ("Borrower"), the undersigned subsidiaries of Borrower and Goldman Sachs Lending Partners LLC ("GSLP"), as Administrative Agent and Collateral Agent.
AMENDMENT NO. 2 TO THIRD AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENTCredit and Guaranty Agreement • November 5th, 2012 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 2 TO Third AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT, dated as of September 10, 2012 (this "Amendment No. 2"), by and among VALEANT PHARMACEUTICALS INTERNATIONAL, Inc., a corporation continued under the federal laws of Canada ("Borrower"), the Guarantors, Goldman Sachs Lending Partners LLC, as Administrative Agent ("Administrative Agent") and Collateral Agent under the Credit Agreement (as defined below), and the Requisite Lenders.
SEPARATION AGREEMENTSeparation Agreement • November 5th, 2012 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations
SEPARATION AGREEMENT dated the 13th day of September, 2012 between VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (“Valeant”) and Rajiv De Silva (“Mr. De Silva” and together with Valeant, the "Parties").
